Clinical Trials Directory

Trials / Completed

CompletedNCT04686825

The Food Effect on Pharmacokinetics of DA-8010 After a Single Administration of DA-8010 2.5 mg or 5 mg in Healthy Subjects

A Randomized, Open-label, Single-dose, 4-way Crossover Phase 1 Study to Evaluate the Food Effect on Pharmacokinetics of DA-8010 After a Single Administration of DA-8010 2.5 mg or 5 mg in Healthy Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
29 (actual)
Sponsor
Dong-A ST Co., Ltd. · Industry
Sex
All
Age
19 Years – 50 Years
Healthy volunteers
Accepted

Summary

This is a randomized, open-label, single-dose, 4-way crossover phase 1 study to evaluate the food effect on pharmacokinetics of DA-8010 after a single administration of DA-8010 2.5 mg or 5 mg under fasting and fed states in healthy male and female subjects

Conditions

Interventions

TypeNameDescription
DRUGDA-8010 2.5mg (Fasting)Test drug l : DA-8010 2.5mg (Fasting)
DRUGDA-8010 2.5mg (Fed)Test drug ll : DA-8010 2.5mg (Fed)
DRUGDA-8010 5mg (Fasting)Test drug llI : DA-8010 5mg (Fasting)
DRUGDA-8010 5mg (Fed)Test drug lV : DA-8010 5mg (Fed)

Timeline

Start date
2021-01-13
Primary completion
2021-02-17
Completion
2021-03-11
First posted
2020-12-29
Last updated
2021-05-26

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04686825. Inclusion in this directory is not an endorsement.